Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

CK Life Sciences' Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting
Healthcare & PharmaceuticalCompany Update

CK Life Sciences' Sequencio Therapeutics Presents the Latest Vaccine Research Advancements at the American Association for Cancer Research Annual Meeting

March 31, 2026 7:15 AM

Sequencio Therapeutics Company Limited ("Sequencio"), a subsidiary of CK Life Sciences Int'l., (Holdings) Inc. ("CK Life Sciences"), today announced that five research abstracts will be presented at the American Association for Cancer Research ("AACR") Annual Meeting 2026, taking place 17-22 April 2026 in San Diego, USA.These presentations mark Sequencio's first major scientific unveiling since its formation and showcase significant advancements...

Read more
Wiley Launches
Healthcare & PharmaceuticalProduct Announcements

Wiley Launches "The Black Book of Reshoring: The Essential Guide to America's New Manufacturing Boom" by Douglas Brown

March 31, 2026 5:00 AM

Wiley today announced the international launch of "The Black Book of Reshoring: The Essential Guide to America's New Manufacturing Boom" by Douglas Brown, a new book for executives, policymakers, investors, manufacturers, and media tracking the fast-changing economics of industrial production. The book arrives as reshoring, tariff pressure, supply-chain disruption, production realignment, and factory investment redraw the map of global...

Read more
Genflow Biosciences PLC Announces Total Voting Rights
Healthcare & PharmaceuticalRegulatory

Genflow Biosciences PLC Announces Total Voting Rights

March 31, 2026 2:45 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company") announces that the total issued share capital of the Company as at 31 March 2026 consists of 535,653,205 ordinary shares of £0.0003 each, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 535,653,205.The figure of 535,653,205 ordinary shares may be used by shareholders of the Company as the denominator for the...

Read more
Benefits of Accessing Professional Support From Home According to Home Based Recovery: An Online Addiction Treatment & Mental Health Counselling
Healthcare & PharmaceuticalCompany Update

Benefits of Accessing Professional Support From Home According to Home Based Recovery: An Online Addiction Treatment & Mental Health Counselling

March 31, 2026 12:50 AM

Accessing professional support no longer requires stepping away from everyday life. Many people today prefer receiving guidance from home, where they feel more comfortable, private, and in control of their environment. Home-based support allows individuals to focus on personal well-being without disrupting work, family, or daily responsibilities. This approach brings care into real life rather than asking people to pause it. By reducing...

Read more
Dr. Marjorie Belsky Calls for Greater Support for Women in Medicine and Healthcare Leadership
Healthcare & PharmaceuticalCompany Update

Dr. Marjorie Belsky Calls for Greater Support for Women in Medicine and Healthcare Leadership

March 30, 2026 8:15 PM

Across the healthcare industry, women now make up a large share of the workforce. Yet many still face barriers to leadership, recognition, and equal professional footing. Physician and attorney Dr. Marjorie Belsky, MD, JD, is raising awareness about those challenges and encouraging more open conversations about equity in medical workplaces.With more than two decades in anesthesiology, pain management, and healthcare leadership, Dr. Belsky has...

Read more
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Healthcare & PharmaceuticalEarnings

Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results

March 30, 2026 4:50 PM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for novel therapeutics while reducing the potential for abuse and overdose, today reported financial and operational results for the fourth quarter and full year ended December 31, 2025."2025 was a year of meaningful progress for Ensysce, marked by significant clinical advancement, productive regulatory...

Read more
Pro Athletes Spent Years Navigating Broken Healthcare. Now They're Building the Fix
Healthcare & PharmaceuticalCompany Update

Pro Athletes Spent Years Navigating Broken Healthcare. Now They're Building the Fix

March 30, 2026 3:00 PM

An unprecedented coalition of NFL players, MLB athletes, surgeons, and sports psychologists has launched ALYZE, an integrated health platform combining diagnostics, hormone optimization, weight loss programs, fitness, recovery, and precision medicine under one roof, with guaranteed measurable progress for every member. Professional athletes spend their careers pushing the limits of human performance. But behind the scenes, many face the same...

Read more
Cordica Medical Appoints Ben Hutson as Chief Operating Officer
Healthcare & PharmaceuticalManagement Changes

Cordica Medical Appoints Ben Hutson as Chief Operating Officer

March 30, 2026 12:00 PM

Cordica Medical, a leading MedTech partner providing advanced medical device design and manufacturing solutions, announced the appointment of Ben Hutson as Chief Operating Officer (COO), effective March 23, 2026. Hutson joins the company as it continues to scale its global platform and expand its capabilities across complex, high-value therapeutic markets.In this role, Hutson will lead global manufacturing, supply chain, and engineering...

Read more
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Healthcare & PharmaceuticalManagement Changes

Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy

March 30, 2026 10:55 AM

Champions Oncology, Inc. (Nasdaq:CSBR), a leading translational oncology research organization, today announced the appointment of Brian Alexander, MD, MPH, to its Board of Directors. Dr. Alexander brings extensive experience at the intersection of oncology, data science, and drug development, having held senior leadership roles at organizations including Valo Health, Flagship Pioneering, and Foundation Medicine. His addition supports Champions'...

Read more
Notice of Annual General Meeting in Ascelia Pharma AB
Healthcare & PharmaceuticalShareholder Meeting

Notice of Annual General Meeting in Ascelia Pharma AB

March 30, 2026 10:45 AM

Ascelia Pharma (STO:ACE) - The shareholders in Ascelia Pharma AB, Reg. No. 556571-8797, are hereby invited to the annual general meeting (Sw. årsstämma) to be held at the premises of Setterwalls Advokatbyrå at Stortorget 23 in Malmö on Monday 4 May 2026 at 2 p.m. CEST.Right to participate and notice of participationShareholders wishing to attend the annual general meeting must:be registered in the company's share register kept by Euroclear...

Read more
Snapshot Recipes App Set to Gain Exposure on
Healthcare & PharmaceuticalPartnerships

Snapshot Recipes App Set to Gain Exposure on "Sibling Revelry" Podcast Featuring Hollywood Star Kate Hudson

March 30, 2026 9:30 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) ("the Company") today announced that its AI-powered mobile application, Snapshot Recipes, is scheduled to be featured through paid advertising placements on the popular podcast "Sibling Revelry", starring globally recognized actress and entrepreneur Kate Hudson and Oliver Hudson. The advertising campaign is expected to commence on April 7, 2026, introducing Snapshot Recipes to a broad,...

Read more
ZetrOZ Systems' sam Wearable Ultrasound Unit Helps Player Get to NCAA Basketball Tournament
Healthcare & PharmaceuticalPartnerships

ZetrOZ Systems' sam Wearable Ultrasound Unit Helps Player Get to NCAA Basketball Tournament

March 30, 2026 9:15 AM

This season, sharpshooting guard Peyton McDaniel guided the James Madison University's women's basketball team to its first NCAA bid in three years. McDaniel relied on the sam® wearable ultrasound device from ZetrOZ Systems to be at her best through the long, strenuous season, leading her to become the latest brand sam® brand ambassador. The JMU Dukes fell to a strong Kentucky squad in the first round, but the team achieved its goal of winning...

Read more
Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce
Healthcare & PharmaceuticalCompany Update

Safe Staffing Requires New Models of Care, Not Just More Clinicians, Says Global Taskforce

March 30, 2026 9:00 AM

A new international report released today by TruMerit™ calls for a fundamental redesign of healthcare workforce models to address global staffing shortages and strengthen patient care. The report, "Safe Staffing Through New Models of Care," presents a systems-based framework to help health leaders, regulators, and policymakers rethink how care teams are structured, how clinicians work together, and how technology can support safer and more...

Read more
Patient Safety Movement Foundation Welcomes Clairity, Dedalus, and Delfina as New Partners to Open Data Pledge
Healthcare & PharmaceuticalPartnerships

Patient Safety Movement Foundation Welcomes Clairity, Dedalus, and Delfina as New Partners to Open Data Pledge

March 30, 2026 9:00 AM

The Patient Safety Movement Foundation (PSMF) today announced that Clairity Inc., Dedalus, and Delfina Care have signed its Open Data Pledge, reinforcing a growing global movement among healthcare and technology leaders to unlock the life-saving potential of clinical data while maintaining the highest standards of privacy and security.The Open Data Pledge represents a shared commitment to ensure that data generated by medical technologies,...

Read more
Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study
Healthcare & PharmaceuticalCompany Update

Revelation Biosciences Inc. Presents Additional Positive Data from Prime Clinical Study

March 30, 2026 9:00 AM

Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company focused on innovative solutions for acute and chronic disease, presented additional positive data analysis from the PRIME Study at the International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2026) in San Diego (March 29 - April 1, 2026). Presented datademonstrated the capability of Gemini to normalize the...

Read more
CVS Health Foundation Invests $2.24 Million To Strengthen Community Health in Charlotte's Historic West End
Healthcare & PharmaceuticalEnvironmental, Social and Governance

CVS Health Foundation Invests $2.24 Million To Strengthen Community Health in Charlotte's Historic West End

March 30, 2026 9:00 AM

Originally published on CVS Health Company NewsThe CVS Health Foundation recently announced the launch of its Health Zone in Charlotte with a $2.24 million investment in the Westside Wellness Collab, led by Local Initiatives Support Corporation (LISC) Charlotte to expand access to health care, healthy food and chronic condition support in Charlotte's Historic West End."Families deserve access to quality care, healthy food and the support...

Read more
Who Is the Best Plastic Surgeon in Seattle, WA?
Healthcare & PharmaceuticalAdvertorial

Who Is the Best Plastic Surgeon in Seattle, WA?

March 30, 2026 6:00 AM

In Seattle's competitive aesthetic-surgery market, "best" is no longer a title patients hand out based on advertising alone. Increasingly, they look for verifiable board certification, specialized training, published research, and whether a surgeon offers techniques that are uncommon even in major metro areas. By those measures, Dr. Javad Sajan of Allure Esthetic has built a strong publicly documented profile in Seattle.Verified Credentials and...

Read more
The Press Conference for 2026 FHC International Future Health Industry Congress is Successfully Held
Healthcare & PharmaceuticalCompany Update

The Press Conference for 2026 FHC International Future Health Industry Congress is Successfully Held

March 30, 2026 5:50 AM

On the occasion of the Boao Forum for Asia Annual Conference 2026, a high-profile event focusing on the future development of the global health industry-the press conference for the 2026 FHC International Future Health Industry Congress-was grandly held in Boao, China. The press conference officially announced that the International Future Health Industry Congress, themed "Wisdom Gathers for Health, Innovation Shapes the Future", will be held...

Read more
BioNxt Advances Semaglutide as First Application of Broad GLP-1 ODF Platform Strategy
Healthcare & PharmaceuticalCompany Update

BioNxt Advances Semaglutide as First Application of Broad GLP-1 ODF Platform Strategy

March 30, 2026 3:05 AM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to provide an update on its semaglutide oral thin-film (ODF) program and its broader strategy to develop a scalable platform for GLP-1 receptor agonists and peptide-based therapeutics.Semaglutide as Lead Candidate for GLP-1 Platform ValidationBioNxt is currently in early-stage...

Read more
Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Healthcare & PharmaceuticalCompany Update

Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting

March 28, 2026 10:05 AM

Protagonist Therapeutics, Inc. (Nasdaq:PTGX) ("Protagonist" or "the Company") today announced new one-year Phase 3 results for ICOTYDE™ (icotrokinra) were presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting. Data from the Phase 3 ICONIC-ADVANCE 1 and 2 and ICONIC-LEAD studies further support the potential of ICOTYDE as a differentiated oral therapy for patients with moderate-to-severe plaque psoriasis."The one-year Phase 3...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?